Where does SeLux Diagnostics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), SeLux Diagnostics, Inc. ranks #15,602 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does SeLux Diagnostics, Inc. hold?

SeLux Diagnostics, Inc. holds 19 US utility patents granted between 2017 and 2025, spanning 12 technology areas.

What is SeLux Diagnostics, Inc.'s Innovation Score?

SeLux Diagnostics, Inc. has an Innovation Score of 54.3 out of 100 (top 8% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is SeLux Diagnostics, Inc.'s patent grant rate increasing or decreasing?

SeLux Diagnostics, Inc.'s recent grant velocity is +225% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for SeLux Diagnostics, Inc.'s patents?

SeLux Diagnostics, Inc.'s patents average 19.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the SeLux Diagnostics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

SeLux Diagnostics, Inc.

Q: What technology areas does SeLux Diagnostics, Inc. focus on?

SeLux Diagnostics, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 17 patents, ranking #279 of 2,502 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

USPTO PatentsView assignee record - 19 granted patents across 12 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Selux ranks #15,602 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 12 technology areas.

#15,602
of 49,997 US assignees by volume: Top 8%
by Innovation Score (54.3/100): 19.6
avg claims per patent: +225%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R15602 · US Corporation #15,602 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 19 grants
MID-PACK #15,602/49,997
PHOTO-FINISH Sandstone Media
CPC-FOCUS C12Q · 12 areas
INNOV-PAR 54.3/100
CLAIMS-RICH 19.6 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +225% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sandstone Media, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Selux’s 54.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.3 pts (19%) Velocity 20.0 pts (37%) Breadth 12.2 pts (23%) Claim depth 11.7 pts (22%)

Qualcomm Incorporated · highest

85
SeLux Diagnostics · this assignee

54
3D Lighting… · lowest

7

What this shows Selux's Innovation Score is 54.3/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Selux?

Each dot is one of Selux’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Selux’s own 19.6 claims/patent is ABOVE the 14.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Selux vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Selux's grants concentrate

SeLux Diagnostics, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 89.5% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2022 (5 grants) versus a trough of 1 in 2017. By volume, Selux sits between Sandstone Media, LLC and Shangyou Jiayi Lighting Product Co., Ltd..

Selux's three-year grant acceleration

SeLux Diagnostics, Inc. shows 11 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Sandstone Media

19
Scale Computing

19
Schmidhauser

19
Scorpcast

19
Select Comfort

19
Sensl

19
Servier Pharmaceu…

19
Shangyou Jiayi Li…

19
Selux Diagnostics ◀

19

What this shows SeLux holds 19 patents at rank #15,632, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near SeLux

By rank, the assignees closest to #15,632 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in SeLux's primary technology class.

Selux's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 8% higher than 92% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

SeLux Diagnostics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	5.3%
2018	2	10.5%
2019	1	5.3%
2021	2	10.5%
2022	5	26.3%
2023	4	21.1%
2024	2	10.5%
2025partial year	2	10.5%

Which technologies does SeLux Diagnostics, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 17

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 12

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 3

C12Y - Enzymes 2

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 2

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 1

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

C07D - Heterocyclic Compounds 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

SeLux Diagnostics, Inc.'s patent record in context - here's where to go next.

SeLux Diagnostics, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 89.5% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #15,602 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare SeLux Diagnostics, Inc. against Sandstone Media, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 54.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.